{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:50:14Z","timestamp":1788922214020,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bmcl.2025.130111","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:10:33Z","timestamp":1737763833000},"page":"130111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel tertiary diarylethylamines as functionally selective agonists of the kappa opioid receptor"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3468-9566","authenticated-orcid":false,"given":"Thomas O.","family":"Schrader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym I.","family":"Lorrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Nelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Broadhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Baccei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130111_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837671","article-title":"The kappa opioid receptor: a promising therapeutic target for multiple pathologies","volume":"13","author":"Dalefield","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130111_b0010","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67523","article-title":"Dual mechanisms of opioid-induced respiratory depression in the inspiratory rhythm-generating network","volume":"10","author":"Baertsch","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.bmcl.2025.130111_b0015","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bmcl.2025.130111_b0020","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1523\/JNEUROSCI.1493-16.2016","article-title":"Identification of the kappa-opioid receptor as a therapeutic target for oligodendrocyte remyelination","volume":"36","author":"Mei","year":"2016","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmcl.2025.130111_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11120","article-title":"Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination","volume":"7","author":"Du","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2025.130111_b0030","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1234","article-title":"Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease","volume":"10","author":"Denny","year":"2021","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.bmcl.2025.130111_b0035","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/jpet.120.000134","article-title":"Strategies for developing \u03ba opioid receptor agonists for the treatment of pain with fewer side effects","volume":"375","author":"Paton","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"issue":"37","key":"10.1016\/j.bmcl.2025.130111_b0040","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1523\/JNEUROSCI.2444-15.2015","article-title":"Kappa opioid receptor-induced aversion requires p38 MAPK activation in VTA dopamine neurons","volume":"35","author":"Ehrich","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmcl.2025.130111_b0045","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/bph.13854","article-title":"Selective \u03ba receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice","volume":"174","author":"Spetea","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130111_b0050","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1021\/acschemneuro.3c00807","article-title":"Identification and in vivo evaluation of myelination agent PIPE-3297, a selective kappa opioid receptor agonist devoid of \u03b2-Arrestin-2 recruitment efficacy","volume":"15","author":"Schrader","year":"2024","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.bmcl.2025.130111_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106091","article-title":"An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects","volume":"177","author":"French","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bmcl.2025.130111_b0060","article-title":"Phenol (bio)isosteres in drug design and development","author":"Dunker","year":"2024","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmcl.2025.130111_b0065","doi-asserted-by":"crossref","first-page":"8956","DOI":"10.1021\/acs.jmedchem.9b02092","article-title":"Positional analogue scanning: an effective strategy for multiparameter optimization in drug design","volume":"63","author":"Pennington","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130111_b0070","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1021\/acsomega.9b02344","article-title":"Lipophilic metabolic efficiency (LipMetE) and drug efficiency indices to explore the metabolic properties of the substrates of selected cytochrome P450 isoforms","volume":"5","author":"Kiani","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmcl.2025.130111_b0075","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1016\/j.bmcl.2009.08.045","article-title":"Using the Golden Triangle to optimize clearance and oral absorption","volume":"19","author":"Johnson","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130111_b0080","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.xphs.2019.02.005","article-title":"Validation of Human MDR1-MDCK and BCRP-MDCK cell lines to improve the prediction of brain penetration","volume":"108","author":"Feng","year":"2019","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bmcl.2025.130111_b0085","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1016\/j.bmcl.2012.08.059","article-title":"How hydrogen bonds impact P-glycoprotein transport and permeability","volume":"22","author":"Desai","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130111_b0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/cn200100h","article-title":"Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery","volume":"3","author":"Ghose","year":"2012","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.bmcl.2025.130111_b0095","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1021\/jm201136z","article-title":"Structural modifications that alter the P-glycoprotein efflux properties of compounds","volume":"55","author":"Hitchcock","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130111_b0100","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1021\/acs.jmedchem.7b00981","article-title":"Highly potent and selective new diphenethylamines interacting with the kappa-opioid receptor: synthesis, pharmacology and structure-activity relationships","volume":"60","author":"Erli","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130111_b0105","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochem Pharmacol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T09:04:27Z","timestamp":1741511067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25000204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":21,"alternative-id":["S0960894X25000204"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130111","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel tertiary diarylethylamines as functionally selective agonists of the kappa opioid receptor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130111"}}